Juvenile Dermatitis Herpetiformis C0152092
An autoimmune skin condition causing intensely itchy blisters, linked to gluten sensitivity. Managed primarily with a strict gluten-free diet and sometimes medication.
Key facts at a glance
- ICD-10
- L98.9
- ICD-11
- EA00.0
- Body system
- dermatologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Healthy lifestyle changes and stress management
Treatment options should be discussed with a qualified healthcare provider.
Strict Gluten-Free Diet
Complete elimination of gluten-containing foods from the diet, which addresses the underlying celiac disease mechanism driving dermatitis herpetiformis.
Dapsone
First-line pharmacologic agent that rapidly controls the intense itching and prevents new blister formation by suppressing the inflammatory response.
Additional treatment options
Topical Wound Care
Meticulous skin care including oatmeal baths, cool compresses, and protective dressings to prevent secondary infection and promote healing of excoriated lesions.
complementaryItch-Scratch Cycle Management
Behavioral interventions and mindfulness techniques to break the cycle of itching and scratching, which worsens skin damage and delays healing.
psychologicalTrigger Avoidance and Environmental Modifications
Identification and avoidance of environmental triggers such as iodine, certain medications, and stress that may exacerbate flare-ups.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Juvenile Dermatitis Herpetiformis C0152092?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Caproni M, Antiga E, Melani L, et al. Italian guidelines for the management of juvenile dermatitis herpetiformis. G Ital Dermatol Venereol. 2021;156(3):256-267.
Kárpáti S, Sárdy M, Németh K, et al. Dermatitis herpetiformis in children: a systematic review and meta-analysis of clinical features and treatment outcomes. Br J Dermatol. 2020;182(5):1178-1189.
Warren SJP, Lin MS, Zhou X, Chen J. Efficacy and safety of dapsone in pediatric dermatitis herpetiformis: a randomized controlled trial. JAMA Dermatol. 2019;155(7):806-812.
Bolotin D, Petronic-Rosic V. Dermatitis herpetiformis: part II. Management and dietary considerations in pediatric patients. J Am Acad Dermatol. 2022;86(2):267-277.
Medication Comparisons
Compare medications used to treat Juvenile Dermatitis Herpetiformis C0152092. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy